Insider · CIK 0001835966

Sandler Alan B.

Reports to the SEC for 5 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001835966

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-29	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+6,000 sh	$58.84	+$353K	58,868
2026-09-29	RVMDRevolution Medicines, Inc.S Sale	Chief Development Officer	SSale	−2,200 sh	$200.82	−$442K	56,668
2026-09-29	RVMDRevolution Medicines, Inc.S Sale	Chief Development Officer	SSale	−1,609 sh	$201.72	−$325K	55,059
2026-09-29	RVMDRevolution Medicines, Inc.S Sale	Chief Development Officer	SSale	−1,000 sh	$202.81	−$203K	54,059
2026-09-29	RVMDRevolution Medicines, Inc.S Sale	Chief Development Officer	SSale	−1,199 sh	$203.91	−$244K	52,860
2026-09-29	RVMDRevolution Medicines, Inc.S Sale	Chief Development Officer	SSale	−301 sh	$204.72	−$61.6K	52,559
2026-09-29	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−6,000 sh	—	—	161,300
2026-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Development Officer	SSale	−5 sh	$194.96	−$974.795	53,204
2026-09-16	RVMDRevolution Medicines, Inc.S Sale	Chief Development Officer	SSale	−336 sh	$199.30	−$67K	52,868
2026-01-20	ALXOALX ONCOLOGY HOLDINGS INC · Stock option (right to buy)A Award	Director	AAward	+10.1K sh	—	—	10,100
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−55K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2025-06-05	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2025-04-11	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)A Award	Director	AAward	+125K sh	—	—	125,000
2025-01-21	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2024-11-18	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)A Award	Director	AAward	+600K sh	—	—	600,000
2024-08-05	ALXOALX ONCOLOGY HOLDINGS INC · Stock Option (right to buy)A Award	Director	AAward	+40.4K sh	—	—	40,400
2024-06-13	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2024-02-29	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−10.5K sh	—	—	69,318
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−52.3K sh	—	—	17,021
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−17K sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−65K sh	—	—	0
2023-12-29	Mirati Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+17K sh	$58.75	+$1M	79,318
2023-08-09	Mirati Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+22.3K sh	$37.00	+$825K	62,297
2022-11-07	Mirati Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+40K sh	—	—	40,000
2022-11-07	Mirati Therapeutics, Inc.Stock Option (Right to buy)A Award	Chief Medical Officer	AAward	+65K sh	—	—	65,000
2022-06-25	ZLABZai Lab Ltd · Restricted Share UnitsA Award	Head of Global Dev., Oncology	AAward	+73K sh	—	—	73,000
2022-04-01	ZLABZai Lab LtdM Exercise/Conversion	Head of Global Dev., Oncology	MExercise/Conversion	+1,060 sh	—	—	28,985
2022-04-01	ZLABZai Lab Ltd · Stock Options (Right to Buy)A Award	Head of Global Dev., Oncology	AAward	+87.7K sh	—	—	87,699
2022-04-01	ZLABZai Lab Ltd · Restricted Share UnitsA Award	Head of Global Dev., Oncology	AAward	+16.7K sh	—	—	16,692
2022-04-01	ZLABZai Lab Ltd · Restricted Share UnitsM Exercise/Conversion	Head of Global Dev., Oncology	MExercise/Conversion	−1,060 sh	—	—	4,240
2021-12-01	ZLABZai Lab LtdF Tax Payment	Head of Global Dev., Oncology	FTax Payment	−2,075 sh	$71.23	−$148K	27,925
2021-04-01	ZLABZai Lab Ltd · Stock Options (Right to Buy)A Award	Head of Global Dev., Oncology	AAward	+28K sh	—	—	28,000
2021-04-01	ZLABZai Lab Ltd · Restricted Share UnitsA Award	Head of Global Dev., Oncology	AAward	+5,300 sh	—	—	5,300

Recent filings

Accepted (ET)
Oct 14
Sandler Alan B.0001835966-26-000008
SEC(opens sec.gov)
Sep 184
Sandler Alan B.0001835966-26-000006
SEC(opens sec.gov)
Jan 214
Sandler Alan B.0001193125-26-018028
SEC(opens sec.gov)
Jul 244
Sandler Alan B.0001415889-25-020241
SEC(opens sec.gov)
Jun 94
Sandler Alan B.0001415889-25-016272
SEC(opens sec.gov)
Apr 154
Sandler Alan B.0001415889-25-010692
SEC(opens sec.gov)
Jan 234
Sandler Alan B.0001415889-25-001963
SEC(opens sec.gov)
Nov 194
Sandler Alan B.0001415889-24-027181
SEC(opens sec.gov)
Aug 74
Sandler Alan B.0001415889-24-020932
SEC(opens sec.gov)
Jun 174
Sandler Alan B.0001415889-24-017213
SEC(opens sec.gov)
Mar 44
Sandler Alan B.0001415889-24-006300
SEC(opens sec.gov)

Companies

Address

REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE

REDWOOD CITY, CA, 94063